Artificial Intelligence and Machine Learning approach based in-silico ADME-Tox and Pharmacokinetic Profile of α-Linolenic acid from Catharanthus roseus (L.) G. Don.

Abstract

Current craze and concomitant rise of Artificial Intelligence and Machine Learning (AI&ML) in the post-COVID-era holds significant contribution to Drug Design and Development. Along with IoT, AI&ML has reduced human interface and improved the Quality of Life though Quality-Health-Care products. AI&ML approaches driven Rational Drug Design along with customised molecular modelling techniques such as in-silico simulation, pharmacophore modelling, molecular dynamics, virtual screening, and molecular docking aims to elucidate unforeseen bioactivity of natural products confined to limited timeframe with at-most perfection. Besides, it also defines the molecular determinants that partake in the interface with in the drug and the target to design more proficient drug leads. α-Linolenic acid (ALA), a carboxylic acid with 18 carbons and three cis double bonds, is an essential fatty acid required for normal human health and can be acquired through regular dietary supplementation of food. During the metabolic process, ALA is bio-transformed into EPA and DHA. ALA decreases the risk of heart disease by maintaining normal heart rhythm and pumping. Studies suggest that ALA is associated with reduced risk of fatal ischemic heart disease further higher intake may reduce the risk of sudden death among prevalent myocardial infarction patients consistent with induced antiarrhythmic effect. It reduces blood clots, besides, cardiovascular-protective, anti-cancer, neuro-protective, anti-osteoporotic, anti-inflammatory, and anti-oxidative effects. However, data on pharmacological and toxicological aspects of ALA is limited; on the other hand, no serious adverse effects of ALA have been reported yet. In the present study AI&ML approach based in-silico ADME-Tox and pharmacokinetic profile of ALA from Catharanthus roseus is envisaged.
 Keywords: IoT; AI&ML; ADME-Tox; α-Linolenic Acid (ALA); EPA; DHA Pharmacokinetics; Catharanthus roseus.

Homoeopathic Pathogenetic Trial of Catharanthus roseus: A Multicentric, Double-Blind, Randomized, Placebo-Controlled Trial

“…As reported in the study of Chopra et al 1 that this drug has sustained hypotensive action and the traditional use 3 of this medicine is to alleviate high blood pressure, in the present study statistically significant change has been noted in the SBP from PME to TME wherein the mean SBP has reduced. Although the finding is in corroboration with the available literature, its effect specifically in reducing SBP may be explored.…”

ADMET-Evaluation, Pharmacokinetics, Drug-likeness and Medicinal Chemistry of GCMS Identified Bioactive Compounds of Moringa oleifera Natural-Ripened-Dried Methanolic Pod Extract (MOMPE) as a Potential Source of Natural Drug Frontrunner for Next Generation

“…Previous studies [38][39][40][41][42][43][44][45][46][47][48][49] indicates that the successful exploitation of plant based natural products depends on the identification, isolation, purification and ADMET characterization followed by clinical trials before its launch in the market. Phytochemical screening and GCMS analysis revealed the presence of 12 compounds namely -7-Octadecyne…”

Phytochemical Screening, GC-MS and FTIR analysis of Bioactive Compounds in Methanolic Leaf Extracts of Costus igneus (CIMLE) as a Natural Source of Drug Lead Molecules for Next-generation Drug-design, Development and Therapeutics

“…The methanolic leaf extracts of Costus igneus were subjected to various chemical tests for the detection of phytoconstituents and GCMS, FTIR analysis using standard procedures described previously [22][23][24][25][26][27][28][29][30][31][32][33][34][35][36][37][38][39][40] .…”